16-4797465-A-G
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_024589.3(ROGDI):c.859T>C(p.Phe287Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000744 in 1,613,156 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_024589.3 missense
Scores
Clinical Significance
Conservation
Publications
- amelocerebrohypohidrotic syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ROGDI | NM_024589.3 | c.859T>C | p.Phe287Leu | missense_variant | Exon 11 of 11 | ENST00000322048.12 | NP_078865.1 | |
ROGDI | XM_006720947.5 | c.880T>C | p.Phe294Leu | missense_variant | Exon 11 of 11 | XP_006721010.1 | ||
ROGDI | XM_047434636.1 | c.610T>C | p.Phe204Leu | missense_variant | Exon 9 of 9 | XP_047290592.1 | ||
ROGDI | NR_046480.2 | n.866T>C | non_coding_transcript_exon_variant | Exon 10 of 10 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000342 AC: 52AN: 152182Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000104 AC: 26AN: 248996 AF XY: 0.0000667 show subpopulations
GnomAD4 exome AF: 0.0000465 AC: 68AN: 1460974Hom.: 0 Cov.: 31 AF XY: 0.0000344 AC XY: 25AN XY: 726802 show subpopulations
GnomAD4 genome AF: 0.000342 AC: 52AN: 152182Hom.: 0 Cov.: 33 AF XY: 0.000309 AC XY: 23AN XY: 74346 show subpopulations
ClinVar
Submissions by phenotype
Amelocerebrohypohidrotic syndrome Uncertain:3
This sequence change replaces phenylalanine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 287 of the ROGDI protein (p.Phe287Leu). This variant is present in population databases (rs149138180, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with ROGDI-related conditions. ClinVar contains an entry for this variant (Variation ID: 663148). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
not specified Uncertain:1
Variant summary: ROGDI c.859T>C (p.Phe287Leu) results in a non-conservative amino acid change in the encoded protein sequence. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change. The variant allele was found at a frequency of 0.0001 in 248996 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in ROGDI causing Amelocerebrohypohidrotic Syndrome, allowing no conclusion about variant significance. To our knowledge, no occurrence of c.859T>C in individuals affected with Amelocerebrohypohidrotic Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 663148). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Inborn genetic diseases Uncertain:1
The c.859T>C (p.F287L) alteration is located in exon 11 (coding exon 11) of the ROGDI gene. This alteration results from a T to C substitution at nucleotide position 859, causing the phenylalanine (F) at amino acid position 287 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at